Raymond James Financial Services Advisors, Inc. Jazz Pharmaceuticals PLC Transaction History
Raymond James Financial Services Advisors, Inc.
- $73.5 Billion
- Q3 2024
A detailed history of Raymond James Financial Services Advisors, Inc. transactions in Jazz Pharmaceuticals PLC stock. As of the latest transaction made, Raymond James Financial Services Advisors, Inc. holds 4,417 shares of JAZZ stock, worth $608,574. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,417
Previous 5,391
18.07%
Holding current value
$608,574
Previous $575,000
14.43%
% of portfolio
0.0%
Previous 0.0%
Shares
28 transactions
Others Institutions Holding JAZZ
# of Institutions
562Shares Held
62.7MCall Options Held
563KPut Options Held
77.8K-
Black Rock Inc. New York, NY6.15MShares$847 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.09MShares$839 Million0.01% of portfolio
-
Lsv Asset Management Chicago, IL2.55MShares$352 Million0.65% of portfolio
-
Capital World Investors Los Angeles, CA2.54MShares$351 Million0.04% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.54MShares$350 Million0.06% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.64B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...